Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A Population-Based Prospective StudyOlav Toai Duc Nguyen, Oluf Dimitri Røe, Ioannis Fotopoulos et al.|JTO Clinical and Research Reports|2024Cited by 6
Promising microRNAs in pre-diagnostic serum associated with lung cancer up to eight years before diagnosis: a HUNT studyIoannis Fotopoulos, Oluf Dimitri Røe, Robin Mjelle et al.|Journal of Cancer Research and Clinical Oncology|2024Cited by 2
The HUNT lung-SNP model: genetic variants plus clinical variables improve lung cancer risk assessment over clinical modelsOlav Toai Duc Nguyen, Oluf Dimitri Røe, Ioannis Fotopoulos et al.|Journal of Cancer Research and Clinical Oncology|2024Cited by 1
Cost‐effectiveness of low‐dose <scp>CT</scp> lung cancer screening among individuals that have ever smoked in Norway: A model‐based analysis using <scp>NELSON</scp> trial criteria and outcomesEmily A. Burger, Natalia Kunst, Dávid Győrbíró et al.|International Journal of Cancer|2025Cited by 1
Towards Personalised Screening for Lung Cancer: A Sex-Stratified Approach in a Danish Cohort Integrating Pre-Diagnostic Systemic Inflammatory Indexes with Smoking Status and AgeMaría del Pilar Fernández Montejo, Zaigham Saghir, Uffe Bodtger et al.|Respiration|2026Cited by 0